| 
		
		 Biden 
		to visit Pfizer factory as Americans clamor for more COVID-19 vaccine 
		supply
   Send a link to a friend 
		[February 19, 2021]  
		By Andrea Shalal and Michael Erman
 WASHINGTON (Reuters) - President Joe Biden 
		heads to Kalamazoo, Michigan, on Friday to visit the Pfizer Inc 
		manufacturing plant that is churning out COVID-19 vaccines, as state and 
		local governments across the country clamor for more.
 | 
        
            | 
			
			 Biden is due to tour Pfizer's largest manufacturing site and its 
			only facility in the United States making the COVID-19 vaccine at a 
			time when less than 15% of the U.S. population is vaccinated. 
 The United States has rolled out ambitious vaccination programs in 
			recent weeks that include large sites capable of putting shots into 
			thousands of arms daily, as well as hospitals and pharmacies. But 
			officials are begging for more doses.
 
 The Biden administration has been working to increase the number of 
			doses it sends out to states, cities and pharmacies every week, but 
			Dr. Anthony Fauci, Biden's top medical adviser, said on Tuesday that 
			demand far outpaced supply at the moment.
 
			
			 
			
 The White House said earlier this month it was using the Defense 
			Production Act to help Pfizer get additional equipment fast so that 
			it could keep ramping up production. Biden is expected to discuss 
			that initiative - which officials say is starting to pay dividends - 
			with Pfizer executives during his tour.
 
 Pfizer has not yet delivered to the European Union about 10 million 
			COVID-19 vaccine doses that were due in December, EU officials told 
			Reuters.
 
 Jeff Williams, mayor of Arlington, Texas, who met with Biden and 
			Treasury Secretary Janet Yellen in recent weeks, said his city of 
			400,000 was ready to vaccinate 40,000 people a day but only had 
			enough supply to administer 3,000 doses.
 
 300 MILLION DOSES
 
 Pfizer is under contract to supply the United States with 300 
			million doses of the two-dose vaccine it developed with Germany’s 
			BioNTech SE.
 
			
            [to top of second column] | 
			
			 The company has said it will 
								provide the U.S. government with 100 million 
								doses by the end of March and another 100 
								million by the end of May. It has promised the 
								full 300 million doses by the end of July.
 As of the end of January, Pfizer had supplied 
								the U.S. government with about 29 million doses 
								of the vaccine. That is about as many doses that 
								had been used by Wednesday, according to U.S. 
								Centers for Disease Control and Prevention data.
 
			Moderna Inc, which is also producing COVID-19 vaccine domestically, 
			has agreed to supply the United States with 300 million doses of its 
			own two-dose vaccine by the end of July.
 Biden told a CNN town hall on Tuesday that everyone who wanted a 
			vaccine should be able to get one by July, but said the recovery 
			from the pandemic that has killed more than 485,000 people in the 
			United States would still take many months.
 
 Globally, Pfizer and BioNTech aim to make 2 billion doses of the 
			COVID-19 vaccine this year. Pfizer’s chief financial officer told 
			Reuters earlier this month that it had recently doubled the size of 
			the batches of its vaccine and increased the number of batches it 
			was producing.
 
 Pfizer is one of the largest employers in the Kalamazoo area, a 
			Democratic-leaning county in the electoral battleground state, which 
			Biden carried in the November election.
 
 (Reporting by Andrea Shalal and Michael Erman; Editing by Peter 
			Cooney)
 
			[© 2021 Thomson Reuters. All rights 
				reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content 
			
			 |